alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with pirenzepine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Semba, K; White, TD | 1 |
Arvanov, V; Jardemark, KE; Liang, X; Wang, RY | 1 |
Alzheimer, C; Seeger, T | 1 |
Jardemark, KE; Ninan, I; Wang, RY | 1 |
Boer, S; Dean, B; Ganfornina, MD; Reinieren, I; Sanchez, D; Scarr, E; Udawela, M; van den Boom, T | 1 |
5 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and pirenzepine
Article | Year |
---|---|
M3 muscarinic receptor-mediated enhancement of NMDA-evoked adenosine release in rat cortical slices in vitro.
Topics: Adenosine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Atropine; Carbachol; Cerebral Cortex; Diamines; Drug Synergism; In Vitro Techniques; Kinetics; Magnesium; Male; Muscarinic Agonists; Muscarinic Antagonists; N-Methylaspartate; Piperidines; Pirenzepine; Rats; Rats, Wistar; Receptor, Muscarinic M3; Receptors, Muscarinic | 1997 |
Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Synergism; Electrophysiology; Excitatory Amino Acid Agonists; Haloperidol; In Vitro Techniques; Male; N-Methylaspartate; Olanzapine; Pharmaceutical Vehicles; Pirenzepine; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Time Factors | 2000 |
Muscarinic activation of inwardly rectifying K(+) conductance reduces EPSPs in rat hippocampal CA1 pyramidal cells.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Carbachol; Cholinergic Agents; Diamines; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Gallamine Triethiodide; Glutamic Acid; Hippocampus; Muscarinic Antagonists; Nicotinic Antagonists; Organ Culture Techniques; Parasympatholytics; Patch-Clamp Techniques; Pirenzepine; Potassium Channels, Inwardly Rectifying; Pyramidal Cells; Rats; Rats, Wistar; Receptor, Muscarinic M2; Receptors, Muscarinic; Stimulation, Chemical | 2001 |
Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-D-aspartate receptors in pyramidal cells of the rat medial prefrontal cortex.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Haloperidol; Male; Membrane Potentials; N-Methylaspartate; Olanzapine; Patch-Clamp Techniques; Phencyclidine; Pirenzepine; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2003 |
Decreased kainate receptors in the hippocampus of apolipoprotein D knockout mice.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Apolipoproteins D; Autoradiography; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Gene Expression Regulation; Hippocampus; Ketanserin; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscarinic Antagonists; Pirenzepine; Protein Binding; Radioligand Assay; Radionuclide Imaging; Receptors, Kainic Acid; Tissue Distribution; Tritium | 2010 |